Astellas Pharma Inc. - ALPMY
Detailed investor-level table based on 13F positions.
Methodology:
Market value and % of portfolio use SEC reported VALUE ($000).
For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received.
Details.
Rows: 0
| Investor | History | Status | Shares held | Market value ($000) | % of portfolio | Previous % | Rank | Change in shares | % change in shares | Source | Date reported |
|---|---|---|---|---|---|---|---|---|---|---|---|
| HANTZ FINANCIAL SERVICES, INC. | History | No change | 189,328 | 2,531 | 0.03% | 0.03% | 1 | 0 | 0.0% | Q2 2026 | Aug 13, 2026 |
| RHUMBLINE ADVISERS | History | No change | 21,642 | 289 | 0.0% | 0.0% | 2 | 0 | 0.0% | Q2 2026 | Aug 11, 2026 |
| GAMMA Investing LLC | History | Added to | 13,511 | 195 | 0.01% | 0.01% | 3 | +1,077 | 8.66% | Q3 2026 | Oct 08, 2026 |
| WELLINGTON-ALTUS USA INC. | History | No change | 2,017 | 31 | 0.02% | 0.02% | 4 | 0 | 0.0% | Q2 2026 | Sep 17, 2026 |
| First Command Advisory Services, Inc. | History | No change | 1,278 | 17 | 0.0% | 0.0% | 5 | 0 | 0.0% | Q2 2026 | Aug 10, 2026 |
| Salomon & Ludwin, LLC | History | No change | 734 | 9 | 0.0% | 0.0% | 6 | 0 | 0.0% | Q2 2026 | Aug 07, 2026 |
| PNC FINANCIAL SERVICES GROUP, INC. | History | No change | 70 | 0 | — | — | — | 0 | 0.0% | Q2 2026 | Aug 07, 2026 |